Related Experiment Videos
Clinical features as predictors of functional status in children with cystic fibrosis
Insights
Clinical features at diagnosis predict cystic fibrosis outcomes in children. Early gastrointestinal symptoms correlate with better prognosis, while respiratory issues suggest potential decline.
Area of Science:
- Pediatric Pulmonology
- Gastroenterology
- Clinical Medicine
Background:
- Cystic fibrosis (CF) presents with significant variability in symptoms and survival rates.
- Predicting the clinical course of CF remains a challenge for effective patient management.
Purpose of the Study:
- To investigate the association between presenting features at diagnosis and the subsequent clinical course in pediatric cystic fibrosis patients.
- To identify early indicators of prognosis in children diagnosed with CF.
Main Methods:
- Retrospective analysis of clinical data from 89 pediatric patients with cystic fibrosis.
- Assessment of presenting symptoms (gastrointestinal vs. respiratory) and initial morbidity levels.
- Evaluation of 5- and 10-year clinical outcomes and survival rates.
Main Results:
- Overall, 5- and 10-year outcomes for pediatric CF patients were more favorable than previously assumed.
- Two-thirds of patients showed stable or improved morbidity levels at 5 years post-diagnosis.
- Children presenting with isolated gastrointestinal symptoms demonstrated a favorable clinical course, with some experiencing improvement.
- Conversely, children with initial respiratory disease often experienced clinical deterioration during follow-up.
- Age at presentation and initial morbidity level did not significantly correlate with subsequent outcomes.
Conclusions:
- Presenting clinical features at diagnosis are valuable prognostic indicators in pediatric cystic fibrosis.
- Early identification of gastrointestinal symptoms suggests a potentially better long-term outlook.
- Respiratory symptoms at diagnosis may indicate a higher risk of clinical deterioration, necessitating closer monitoring.
Abstract:
Previous clinical studies in patients with cystic fibrosis have demonstrated substantial variability in the symptoms present at diagnosis and in subsequent survival rates. In this study we assessed the association between features present at diagnosis and the clinical course of cystic fibrosis in 89 patients. The 5- and 10-year outcomes for children with cystic fibrosis were better than has been generally appreciated. Overall, two thirds of the patients had either improved or remained at the same level of morbidity 5 years after diagnosis. Children who presented with isolated gastrointestinal symptoms had a good clinical course; some actually improved clinically during the first 5 to 10 years after diagnosis. In contrast, children who presented with respiratory disease frequently had clinical deterioration during the follow-up period. Neither age at presentation nor the initial level of morbidity was significantly related to subsequent outcome. We conclude that clinical features apparent at diagnosis are valuable prognostic indicators in children with cystic fibrosis.